Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Gómez-Reino, Juan J
879  Ergebnisse:
Personensuche X
?
1

Malignancy risk with tofacitinib versus TNF inhibitors in r..:

Curtis, Jeffrey R ; Yamaoka, Kunihiro ; Chen, Yi-Hsing...
Annals of the Rheumatic Diseases.  82 (2022)  3 - p. 331-343 , 2022
Link: https://doi.org/10.1136/..
 
?
2

Inmune-mediated inflammatory rheumatic diseases in transgen..:

Salgado, Eva ; Romera-Baurés, Montserrat ; Beltran-Catalan, Emma...
Seminars in Arthritis and Rheumatism.  52 (2022)  - p. 151920 , 2022
Link: https://doi.org/10.1016/..
 
?
3

Impact of baseline body mass index on the efficacy and safe..:

Giles, Jon T ; Ogdie, Alexis ; Gomez-Reino, Juan J...
RMD Open.  7 (2021)  1 - p. e001486 , 2021
Link: https://doi.org/10.1136/..
 
?
4

Update of the position paper of the Spanish Society of Rheu..:

Abad Hernández, Miguel Ángel ; Andreu, José Luis ; Balsa Criado, Alejandro...
Reumatología Clínica (English Edition).  17 (2021)  3 - p. 160-169 , 2021
Link: https://doi.org/10.1016/..
 
?
5

Factors associated with long-term retention of treatment wi..:

Pombo-Suarez, Manuel ; Sanchez-Piedra, Carlos ; Garcia-Magallón, Blanca...
Clinical Rheumatology.  40 (2021)  10 - p. 3979-3988 , 2021
Link: https://doi.org/10.1007/..
 
?
6

Network Meta-Analysis of Tofacitinib, Biologic Disease-Modi..:

Gladman, Dafna D. ; Orbai, Ana-Maria ; Gomez-Reino, Juan...
Current Therapeutic Research.  93 (2020)  - p. 100601 , 2020
Link: https://doi.org/10.1016/..
 
?
7

Clinical features and outcomes of COVID-19 in patients with..:

Sanchez-Piedra, Carlos ; Diaz-Torne, Cesar ; Manero, Javier...
Annals of the Rheumatic Diseases.  79 (2020)  7 - p. 988-990 , 2020
Link: https://doi.org/10.1136/..
 
?
8

Risk/benefit management in the infectious phase in systemic..:

, In: Handbook of Systemic Autoimmune Diseases; Infections in Systemic Autoimmune Diseases: Risk Factors and Management,
Pombo-Suarez, Manuel ; Gomez-Reino, Juan J. - p. 179-203 , 2020
Link: https://doi.org/10.1016/..
 
?
9

Efficacy and safety of Sandoz biosimilar rituximab for acti..:

Smolen, Josef S ; Cohen, Stanley B ; Tony, Hans-Peter...
Rheumatology.  60 (2020)  1 - p. 256-262 , 2020
Link: https://doi.org/10.1093/..
 
?
10

Influence of age on the occurrence of adverse events in rhe..:

Vela, Paloma ; Sanchez-Piedra, Carlos ; Perez-Garcia, Carolina...
Arthritis Research & Therapy.  22 (2020)  1 - p. , 2020
Link: https://doi.org/10.1186/..
 
?
11

Chemical exposure-induced systemic fibrosing disorders: Nov..:

Piera-Velazquez, Sonsoles ; Wermuth, Peter J. ; Gomez-Reino, Juan J...
Seminars in Arthritis and Rheumatism.  50 (2020)  6 - p. 1226-1237 , 2020
Link: https://doi.org/10.1016/..
 
?
12

The role of registries in the treatment of rheumatoid arthr..:

Pombo-Suarez, Manuel ; Gomez-Reino, Juan
Pharmacological Research.  148 (2019)  - p. 104410 , 2019
Link: https://doi.org/10.1016/..
 
?
13

Evaluation of 12 GWAS-drawn SNPs as biomarkers of rheumatoi..:

Ferreiro-Iglesias, Aida ; Montes, Ariana ; Perez-Pampin, Eva...
PLOS ONE.  14 (2019)  2 - p. e0213073 , 2019
Link: https://doi.org/10.1371/..
 
?
14

Efficacy of Tocilizumab in Patients With Moderate-to-Severe..:

Perez-Moreiras, Jose V. ; Gomez-Reino, Juan J. ; Maneiro, Jose R....
American Journal of Ophthalmology.  195 (2018)  - p. 181-190 , 2018
Link: https://doi.org/10.1016/..
 
?
15

Validation study of genetic biomarkers of response to TNF i..:

Lopez-Rodriguez, Rosario ; Perez-Pampin, Eva ; Marquez, Ana...
PLOS ONE.  13 (2018)  5 - p. e0196793 , 2018
Link: https://doi.org/10.1371/..
 
1-15